Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1787940 | 0.89 | KMT2A (0.36) | TSHRALDH1A1SMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL28029632 | 0.87 | TSHR (0.38) | TSHRALDH1A1SMN1; SMN2LMNAPOLB | |
| SCHEMBL9363325 | 0.81 | POLB (0.39) | TSHRALDH1A1SMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL8744673 | 0.80 | TSHR (0.39) | TSHRALDH1A1SMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL8830782 | 0.78 | POLB (0.42) | ALDH1A1SMN1; SMN2LMNAPOLBSLC6A3 | |
| SCHEMBL27962994 | 0.77 | MAOB (0.36) | TSHRALDH1A1SMN1; SMN2L3MBTL1CCR5 | |
| SCHEMBL8744676 | 0.77 | TSHR (0.37) | TSHRALDH1A1SMN1; SMN2LMNAPOLB | |
| SCHEMBL2033491 | 0.72 | POLB (0.43) | ALDH1A1SMN1; SMN2LMNAPOLBSLC6A3 | |
| SCHEMBL15641263 | 0.71 | MAOB (0.37) | TSHRALDH1A1SMN1; SMN2L3MBTL1CCR5 | |
| SCHEMBL2034156 | 0.71 | TRPA1 (0.36) | TSHRALDH1A1SMN1; SMN2CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110124877-A1 | 5-BENZYL-4-AZOLYLMETHYL-4-SPIRO[2.4]HEPTANOL DERIVATIVES, METHODS FOR PRODUCING THE SAME, AND AGRO-HORTICULTURAL AGENTS AND INDUSTRIAL MATERIAL PROTECTING AGENTS THEREOF | KUREHA CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
| EP-2315752-A1 | 5-BENZYL-4-AZOLYLMETHYL-4-SPIRO[2.4]HEPTANOL DERIVATIVES, METHODS FOR PRODUCING THE SAME, AND AGRO-HORTICULTURAL AGENTS AND INDUSTRIAL MATERIAL PROTECTING AGENTS THEREOF | Kureha Corporation (JP) | 2011-05-04 | — | — | EP | disclosed |
| WO-2010023862-A1 | 5-BENZYL-4-AZOLYLMETHYL-4-SPIRO[2.4]HEPTANOL DERIVATIVES, METHODS FOR PRODUCING THE SAME, AND AGRO-HORTICULTURAL AGENTS AND INDUSTRIAL MATERIAL PROTECTING AGENTS THEREOF | KUREHA CORPORATION (JP) | 2010-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124877-A1 | 5-BENZYL-4-AZOLYLMETHYL-4-SPIRO[2.4]HEPTANOL DERIVATIVES, METHODS FOR PRODUCING THE SAME, AND AGRO-HORTICULTURAL AGENTS AND INDUSTRIAL MATERIAL PROTECTING AGENTS THEREOF | CYP8B1, CBR3, CBR1 | TSHR 3518/4885ALDH1A1 861/4885SMN1; SMN2 3743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.